FORA Capital
AMRX icon

FORA Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

FORA Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260K Buy
+12,921
New +$233K 0.01% 510

Other funds holding AMRX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

FORA Capital's AMRX Position: Q3 2026 in Review

FORA Capital opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 12,921 shares worth $260K. The stake represents 0.01% of the portfolio and ranks #510 among its holdings.

264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • FORA Capital held 12,921 shares of Amneal Pharmaceuticals worth $260K as of Q3 2026.
  • Amneal Pharmaceuticals was a new FORA Capital position in Q3 2026.
  • Amneal Pharmaceuticals made up 0.01% of FORA Capital's portfolio in Q3 2026, its #510 holding.
  • 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on FORA Capital's 13F filing for Q3 2026, filed 13 Nov 2026.